News Allergan negotiates option to buy neurology biotech Allergan to co-develop Parkinson's drug with Lysosomal Therapeutics
News Verily’s ‘smart spoon’ combats Parkinson’s tremors Device allows those with neurodegenerative disorders to eat without spilling their food.
News Acorda aims for leadership in Parkinson's disease with acqui... US specialist pharma company Acorda is to acquire Biotie for $363 million, a move which it hopes will make it a leader in Parkinson's disease treatments.
News Neurogene drops high-dose arm in Rett study after death The patient affected by a serious adverse event in Neurogene's clinical trial of Rett syndrome gene therapy has now died
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
